NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC)

CUSIP: 64130M209

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value, $0.001 per share
Shares outstanding
50,013,453
Total 13F shares
409,378
Share change
-20,461
Total reported value
$686,000
Price per share
$1.69
Number of holders
9
Value change
+$3,717
Number of buys
5
Number of sells
4

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AWM Investment Company, Inc.
13F
Company
class O/S missing
1,363,331
$1,119,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
0.48%
239,391
$197,000 30 Jun 2022
13F
DRIVE WEALTH MANAGEMENT, LLC
13F
Company
0.13%
66,667
$55,000 30 Jun 2022
13F
Kingsbury Capital Investment Advisors LLC
13F
Company
0.11%
53,403
$44,000 30 Jun 2022
13F
Intersect Capital LLC
13F
Company
0.1%
50,000
$41,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.1%
48,716
$39,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.03%
15,376
$13,000 30 Jun 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
5,405
$4,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0%
881
$1,000 30 Jun 2022
13F

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q3 2022

As of 30 Sep 2022, NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 409,378 shares. The largest 9 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, DRIVE WEALTH MANAGEMENT, LLC, MAI Capital Management, STATE STREET CORP, JANE STREET GROUP, LLC, Newport Capital Group, LLC, NORTHERN TRUST CORP, and Tower Research Capital LLC (TRC). This page lists 9 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
8
Q3 2022 holders
9
Holder diff
1
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.